These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7955798)

  • 21. The influence of age on the pharmacokinetics of verapamil.
    Ahmed JH; Meredith PA; Elliott HL
    Pharmacol Res; 1991 Oct; 24(3):227-33. PubMed ID: 1956867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiovascular effects of (R)- and (S)-verapamil and racemic verapamil in humans: a placebo-controlled study.
    Busse D; Templin S; Mikus G; Schwab M; Hofmann U; Eichelbaum M; Kivistö KT
    Eur J Clin Pharmacol; 2006 Aug; 62(8):613-9. PubMed ID: 16823584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Population analyses of sustained-release verapamil in patients: effects of sex, race, and smoking.
    Kang D; Verotta D; Krecic-Shepard ME; Modi NB; Gupta SK; Schwartz JB
    Clin Pharmacol Ther; 2003 Jan; 73(1):31-40. PubMed ID: 12545141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. R-verapamil: pharmacokinetics and effects on PR interval, blood pressure and heart rate.
    Ahmed JH; Godden J; Meredith PA; Elliott HL
    Br J Clin Pharmacol; 1993 Aug; 36(2):93-8. PubMed ID: 8398588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aging effects on the organic base transporter and stereoselective renal clearance.
    Ujhelyi MR; Bottorff MB; Schur M; Roll K; Zhang H; Stewart J; Markel ML
    Clin Pharmacol Ther; 1997 Aug; 62(2):117-28. PubMed ID: 9284847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction of steady-state verapamil plasma concentrations in children and adults.
    Wagner JG; Rocchini AP; Vasiliades J
    Clin Pharmacol Ther; 1982 Aug; 32(2):172-81. PubMed ID: 7094504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Steady-state clearance rates of warfarin and its enantiomers in therapeutically dosed patients.
    McAleer SD; Foondun AS; Feely M; Chrystyn H
    Chirality; 1997; 9(1):13-6. PubMed ID: 9094197
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetic interaction between verapamil and metoprolol in the dog. Stereochemical aspects.
    Murthy SS; Nelson WL; Shen DD; Power JM; Cahill CM; McLean AJ
    Drug Metab Dispos; 1991; 19(6):1093-100. PubMed ID: 1687016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of age on pharmacokinetics and pharmacodynamics in man.
    Klotz U
    Int J Clin Pharmacol Ther; 1998 Nov; 36(11):581-5. PubMed ID: 9849746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential induction of prehepatic and hepatic metabolism of verapamil by rifampin.
    Fromm MF; Busse D; Kroemer HK; Eichelbaum M
    Hepatology; 1996 Oct; 24(4):796-801. PubMed ID: 8855178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of calcium channel blockers on the pharmacokinetics of propranolol stereoisomers.
    Hunt BA; Bottorff MB; Herring VL; Self TH; Lalonde RL
    Clin Pharmacol Ther; 1990 May; 47(5):584-91. PubMed ID: 2344707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enantioselective kinetics of verapamil and norverapamil in isolated perfused rat livers.
    Mehvar R; Reynolds JM; Robinson MA; Longstreth JA
    Pharm Res; 1994 Dec; 11(12):1815-9. PubMed ID: 7899248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Age-associated stereoselective alterations in hexobarbital metabolism.
    Chandler MH; Scott SR; Blouin RA
    Clin Pharmacol Ther; 1988 Apr; 43(4):436-41. PubMed ID: 3356087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. St John's wort decreases the bioavailability of R- and S-verapamil through induction of the first-pass metabolism.
    Tannergren C; Engman H; Knutson L; Hedeland M; Bondesson U; Lennernäs H
    Clin Pharmacol Ther; 2004 Apr; 75(4):298-309. PubMed ID: 15060508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The enantiomer-specific kinetics and dynamics of verapamil after rapid intravenous administration to sheep: physiological analysis and modeling.
    Huang YF; Upton RN; Zheng D; McLean C; Gray EC; Grant C
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1048-57. PubMed ID: 9495866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stereoselective steady state disposition and action of propafenone in Chinese subjects.
    Li G; Gong PL; Qiu J; Zeng FD; Klotz U
    Br J Clin Pharmacol; 1998 Nov; 46(5):441-5. PubMed ID: 9833596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enantiomer-selective pharmacokinetics and metabolism of ketorolac in children.
    Kauffman RE; Lieh-Lai MW; Uy HG; Aravind MK
    Clin Pharmacol Ther; 1999 Apr; 65(4):382-8. PubMed ID: 10223774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stereoselective disposition of mexiletine in man.
    Grech-Belanger O; Turgeon J; Gilbert M
    Br J Clin Pharmacol; 1986 May; 21(5):481-7. PubMed ID: 3718807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of thiopental and pentobarbital enantiomers after intravenous administration of racemic thiopental.
    Nguyen KT; Stephens DP; McLeish MJ; Crankshaw DP; Morgan DJ
    Anesth Analg; 1996 Sep; 83(3):552-8. PubMed ID: 8780280
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of prilocaine after intravenous administration in volunteers: enantioselectivity.
    van der Meer AD; Burm AG; Stienstra R; van Kleef JW; Vletter AA; Olieman W
    Anesthesiology; 1999 Apr; 90(4):988-92. PubMed ID: 10201668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.